Načítá se...

Evolutionary Modeling of Combination Treatment Strategies To Overcome Resistance to Tyrosine Kinase Inhibitors in Non-Small Cell Lung Cancer

[Image: see text] Many initially successful anticancer therapies lose effectiveness over time, and eventually, cancer cells acquire resistance to the therapy. Acquired resistance remains a major obstacle to improving remission rates and achieving prolonged disease-free survival. Consequently, novel...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Mumenthaler, Shannon M., Foo, Jasmine, Leder, Kevin, Choi, Nathan C., Agus, David B., Pao, William, Mallick, Parag, Michor, Franziska
Médium: Artigo
Jazyk:Inglês
Vydáno: American Chemical Society 2011
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3230244/
https://ncbi.nlm.nih.gov/pubmed/21995722
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1021/mp200270v
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!